Candel Therapeutics CTO Seshu Tyagarajan sells 7,000 shares for $84,000
CADL•Insider sale details
Candel Therapeutics CTO Seshu Tyagarajan sold 7,000 common shares on Aug. 17, 2026 at $12.
Holdings fell to 76,865 shares following the transaction.
CADL•Candel Therapeutics CTO Seshu Tyagarajan sold 7,000 common shares on Aug. 17, 2026 at $12.
Holdings fell to 76,865 shares following the transaction.
